Search
-
Opposition keeps spotlight on arms deal as coalition looks for way out
PoliticsGreek Politicsproperty auctions, which began on Wednesday. Although they are small in number and concern high value real
4% -
PMI up to 53.1 in Dec as business conditions improve at fastest pace in over a decade
EconomyMacroeconomytheir gross margins. The industry’s confidence improved by the highest margin since the series began
4% -
SYRIZA looks towards bailout finishing line and beyond
PoliticsGreek Politicsdiscussions that began in New York this week, but with the main focus being on the completion
4% -
Economic sentiment at 101.9 pts in Jan, consumer confidence dips by 0.7 pts
EconomyMacroeconomymark. Greece’s ESI began to slide in the third quarter of 2008 when the global credit crunch hit
4% -
Overdue social security debt reaches 31.3 bln in Q4, collected revenues beat annual target
EconomyMacroeconomystock, corresponding to 78.8 percent of the total figure, was created by debtors who began
4% -
Greece issues 7-year bond, moves closer to wrapping up third review
EconomyProgrammeEuclid Tsakalotos and Prime Minister Alexis Tsipras during his visit to Athens, which began on Thursday
4% -
Newsletter 150 -26/01/2018
issue to trying to turn the tables on its opponents via an alleged bribery scandal. The week began
4% -
Tsipras confirms Parliament will probe contentious Novartis bribery claims
PoliticsGreek Politicsthat began few days ago will have plenty of time to intensify as the process will last several months
4% -
Three in 10 workers in part-time jobs, earning less than 400 euros
Society2016 was not available since the fund began operating as of January 1, 2017. The data also revealed
4% -
Parties clash over Novartis allegations in sign of things to come
PoliticsGreek PoliticsGreek Parliament began debating on Wednesday morning the Novartis bribery allegations, with the aim of deciding in a late-night vote whether MPs should launch an inquiry into the clams that as many as 10 politicians accepted under-the-table payments from the Swiss pharmaceutical giant. As expected
4%